YTHDC1 Antikörper (AA 89-153) (HRP)
-
- Target Alle YTHDC1 Antikörper anzeigen
- YTHDC1 (YTH Domain Containing 1 (YTHDC1))
-
Bindungsspezifität
- AA 89-153
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser YTHDC1 Antikörper ist konjugiert mit HRP
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human YTH domain-containing protein 1 protein (89-153AA)
- Isotyp
- IgG
- Top Product
- Discover our top product YTHDC1 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- YTHDC1 (YTH Domain Containing 1 (YTHDC1))
- Andere Bezeichnung
- YTHDC1 (YTHDC1 Produkte)
- Synonyme
- C80342 antikoerper, mKIAA1966 antikoerper, A730098D12Rik antikoerper, zgc:101592 antikoerper, MGC89461 antikoerper, MGC137509 antikoerper, DKFZp459L1228 antikoerper, YT521 antikoerper, YT521-B antikoerper, Yt521 antikoerper, YTH domain containing 1 antikoerper, YTH domain containing 1 L homeolog antikoerper, Ythdc1 antikoerper, YTHDC1 antikoerper, ythdc1 antikoerper, ythdc1.L antikoerper
- Hintergrund
-
Background: Regulator of alternative splicing that specifically recognizes and binds N6-methyladenosine (m6A)-containing RNAs (PubMed:26318451, PubMed:26876937, PubMed:25242552). M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in the efficiency of mRNA splicing, processing and stability (PubMed:26318451, PubMed:25242552). Acts as a key regulator of exon-inclusion or exon-skipping during alternative splicing via interaction with mRNA splicing factors SRSF3 and SRSF10 (PubMed:26876937). Specifically binds m6A-containing mRNAs and promotes recruitment of SRSF3 to its mRNA-binding elements adjacent to m6A sites, leading to exon-inclusion during alternative splicing (PubMed:26876937). In contrast, interaction with SRSF3 prevents interaction with SRSF10, a splicing factor that promotes exon skipping: this prevents SRSF10 from binding to its mRNA-binding sites close to m6A-containing regions, leading to inhibit exon skipping during alternative splicing (PubMed:26876937). May also regulate alternative splice site selection (PubMed:20167602).
Aliases: YTHDC1 antibody, KIAA1966 antibody, YT521 antibody, YTH domain-containing protein 1 antibody, Splicing factor YT521 antibody, YT521-B antibody
- UniProt
- Q96MU7
-